Common germline-somatic variant interactions in advanced urothelial cancer
Aram Vosoughi(Cornell University), Bishoy M. Faltas(Cornell University), Ana M. Molina(Cornell University), Kyrillus S. Shohdy(Cornell University), Wendy K. Chung(Oregon Health & Science University), David M. Nanus(Cornell University), Bhavneet Bhinder(Cornell University), Mark A. Rubin(University of Bern), Jenny Xiang(Cornell University), Juan Miguel Mosquera(NewYork–Presbyterian Hospital), Andrea Sboner(Cornell University), Himisha Beltran(Dana-Farber Cancer Institute), Brian D. Robinson(Cornell University), Panagiotis J. Vlachostergios(NewYork–Presbyterian Hospital), Olivier Elemento(Cornell University), Xiao Fan(Columbia University Irving Medical Center), David Wilkes(Cornell University), Tuo Zhang(Cornell University), Cora N. Sternberg(Cornell University), Samaneh Motanagh(Cornell University), Scott T. Tagawa(Cornell University)
Cited by 43
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k